Viral and Non-Viral Vector Manufacturing Market, Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of Viral and Non-Viral Vector Manufacturing in Global, including the following market information:
Global Viral and Non-Viral Vector Manufacturing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Viral and Non-Viral Vector Manufacturing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Viral Vectors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Viral and Non-Viral Vector Manufacturing include Boehringer Ingelheim, Catalent, Inc., FUJIFILM Holdings Corporation, Danaher Corporation, Genscript Biotech Corporation, Lonza Group AG, Merck KGaA Inc., Oxford Biomedica Plc and Sartorius AG, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Viral and Non-Viral Vector Manufacturing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Viral and Non-Viral Vector Manufacturing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Viral and Non-Viral Vector Manufacturing Market Segment Percentages, by Type, 2021 (%)
Global Viral and Non-Viral Vector Manufacturing Market Segment Percentages, by Application, 2021 (%)
Global Viral and Non-Viral Vector Manufacturing Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Viral and Non-Viral Vector Manufacturing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Viral and Non-Viral Vector Manufacturing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Viral and Non-Viral Vector Manufacturing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Viral and Non-Viral Vector Manufacturing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Viral Vectors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Viral and Non-Viral Vector Manufacturing include Boehringer Ingelheim, Catalent, Inc., FUJIFILM Holdings Corporation, Danaher Corporation, Genscript Biotech Corporation, Lonza Group AG, Merck KGaA Inc., Oxford Biomedica Plc and Sartorius AG, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Viral and Non-Viral Vector Manufacturing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Viral and Non-Viral Vector Manufacturing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Viral and Non-Viral Vector Manufacturing Market Segment Percentages, by Type, 2021 (%)
- Viral Vectors
- Non-Viral Vectors
Global Viral and Non-Viral Vector Manufacturing Market Segment Percentages, by Application, 2021 (%)
- Gene Therapy
- Vaccinology
- Cell Therapy
- Others
Global Viral and Non-Viral Vector Manufacturing Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Viral and Non-Viral Vector Manufacturing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Viral and Non-Viral Vector Manufacturing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Boehringer Ingelheim
- Catalent, Inc.
- FUJIFILM Holdings Corporation
- Danaher Corporation
- Genscript Biotech Corporation
- Lonza Group AG
- Merck KGaA Inc.
- Oxford Biomedica Plc
- Sartorius AG
- Takara Bio Inc.
- Thermo Fisher Scientific Inc.
- Wuxi AppTec
- Acuitas Therapeutics
- Evonik Industries AG
- Exelead, Inc.
- Entos Pharmaceuticals
- Genevant Sciences GmbH
- T&T Scientific Corporation
- Moderna, Inc.
- CureVac N.V.
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Viral and Non-Viral Vector Manufacturing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Viral and Non-Viral Vector Manufacturing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL VIRAL AND NON-VIRAL VECTOR MANUFACTURING OVERALL MARKET SIZE
2.1 Global Viral and Non-Viral Vector Manufacturing Market Size: 2021 VS 2028
2.2 Global Viral and Non-Viral Vector Manufacturing Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Viral and Non-Viral Vector Manufacturing Players in Global Market
3.2 Top Global Viral and Non-Viral Vector Manufacturing Companies Ranked by Revenue
3.3 Global Viral and Non-Viral Vector Manufacturing Revenue by Companies
3.4 Top 3 and Top 5 Viral and Non-Viral Vector Manufacturing Companies in Global Market, by Revenue in 2021
3.5 Global Companies Viral and Non-Viral Vector Manufacturing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Viral and Non-Viral Vector Manufacturing Players in Global Market
3.6.1 List of Global Tier 1 Viral and Non-Viral Vector Manufacturing Companies
3.6.2 List of Global Tier 2 and Tier 3 Viral and Non-Viral Vector Manufacturing Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Viral and Non-Viral Vector Manufacturing Market Size Markets, 2021 & 2028
4.1.2 Viral Vectors
4.1.3 Non-Viral Vectors
4.2 By Type - Global Viral and Non-Viral Vector Manufacturing Revenue & Forecasts
4.2.1 By Type - Global Viral and Non-Viral Vector Manufacturing Revenue, 2017-2022
4.2.2 By Type - Global Viral and Non-Viral Vector Manufacturing Revenue, 2023-2028
4.2.3 By Type - Global Viral and Non-Viral Vector Manufacturing Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Viral and Non-Viral Vector Manufacturing Market Size, 2021 & 2028
5.1.2 Gene Therapy
5.1.3 Vaccinology
5.1.4 Cell Therapy
5.1.5 Others
5.2 By Application - Global Viral and Non-Viral Vector Manufacturing Revenue & Forecasts
5.2.1 By Application - Global Viral and Non-Viral Vector Manufacturing Revenue, 2017-2022
5.2.2 By Application - Global Viral and Non-Viral Vector Manufacturing Revenue, 2023-2028
5.2.3 By Application - Global Viral and Non-Viral Vector Manufacturing Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Viral and Non-Viral Vector Manufacturing Market Size, 2021 & 2028
6.2 By Region - Global Viral and Non-Viral Vector Manufacturing Revenue & Forecasts
6.2.1 By Region - Global Viral and Non-Viral Vector Manufacturing Revenue, 2017-2022
6.2.2 By Region - Global Viral and Non-Viral Vector Manufacturing Revenue, 2023-2028
6.2.3 By Region - Global Viral and Non-Viral Vector Manufacturing Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Viral and Non-Viral Vector Manufacturing Revenue, 2017-2028
6.3.2 US Viral and Non-Viral Vector Manufacturing Market Size, 2017-2028
6.3.3 Canada Viral and Non-Viral Vector Manufacturing Market Size, 2017-2028
6.3.4 Mexico Viral and Non-Viral Vector Manufacturing Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Viral and Non-Viral Vector Manufacturing Revenue, 2017-2028
6.4.2 Germany Viral and Non-Viral Vector Manufacturing Market Size, 2017-2028
6.4.3 France Viral and Non-Viral Vector Manufacturing Market Size, 2017-2028
6.4.4 U.K. Viral and Non-Viral Vector Manufacturing Market Size, 2017-2028
6.4.5 Italy Viral and Non-Viral Vector Manufacturing Market Size, 2017-2028
6.4.6 Russia Viral and Non-Viral Vector Manufacturing Market Size, 2017-2028
6.4.7 Nordic Countries Viral and Non-Viral Vector Manufacturing Market Size, 2017-2028
6.4.8 Benelux Viral and Non-Viral Vector Manufacturing Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Viral and Non-Viral Vector Manufacturing Revenue, 2017-2028
6.5.2 China Viral and Non-Viral Vector Manufacturing Market Size, 2017-2028
6.5.3 Japan Viral and Non-Viral Vector Manufacturing Market Size, 2017-2028
6.5.4 South Korea Viral and Non-Viral Vector Manufacturing Market Size, 2017-2028
6.5.5 Southeast Asia Viral and Non-Viral Vector Manufacturing Market Size, 2017-2028
6.5.6 India Viral and Non-Viral Vector Manufacturing Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Viral and Non-Viral Vector Manufacturing Revenue, 2017-2028
6.6.2 Brazil Viral and Non-Viral Vector Manufacturing Market Size, 2017-2028
6.6.3 Argentina Viral and Non-Viral Vector Manufacturing Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Viral and Non-Viral Vector Manufacturing Revenue, 2017-2028
6.7.2 Turkey Viral and Non-Viral Vector Manufacturing Market Size, 2017-2028
6.7.3 Israel Viral and Non-Viral Vector Manufacturing Market Size, 2017-2028
6.7.4 Saudi Arabia Viral and Non-Viral Vector Manufacturing Market Size, 2017-2028
6.7.5 UAE Viral and Non-Viral Vector Manufacturing Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Boehringer Ingelheim
7.1.1 Boehringer Ingelheim Corporate Summary
7.1.2 Boehringer Ingelheim Business Overview
7.1.3 Boehringer Ingelheim Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.1.4 Boehringer Ingelheim Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2017-2022)
7.1.5 Boehringer Ingelheim Key News
7.2 Catalent, Inc.
7.2.1 Catalent, Inc. Corporate Summary
7.2.2 Catalent, Inc. Business Overview
7.2.3 Catalent, Inc. Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.2.4 Catalent, Inc. Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2017-2022)
7.2.5 Catalent, Inc. Key News
7.3 FUJIFILM Holdings Corporation
7.3.1 FUJIFILM Holdings Corporation Corporate Summary
7.3.2 FUJIFILM Holdings Corporation Business Overview
7.3.3 FUJIFILM Holdings Corporation Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.3.4 FUJIFILM Holdings Corporation Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2017-2022)
7.3.5 FUJIFILM Holdings Corporation Key News
7.4 Danaher Corporation
7.4.1 Danaher Corporation Corporate Summary
7.4.2 Danaher Corporation Business Overview
7.4.3 Danaher Corporation Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.4.4 Danaher Corporation Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2017-2022)
7.4.5 Danaher Corporation Key News
7.5 Genscript Biotech Corporation
7.5.1 Genscript Biotech Corporation Corporate Summary
7.5.2 Genscript Biotech Corporation Business Overview
7.5.3 Genscript Biotech Corporation Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.5.4 Genscript Biotech Corporation Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2017-2022)
7.5.5 Genscript Biotech Corporation Key News
7.6 Lonza Group AG
7.6.1 Lonza Group AG Corporate Summary
7.6.2 Lonza Group AG Business Overview
7.6.3 Lonza Group AG Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.6.4 Lonza Group AG Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2017-2022)
7.6.5 Lonza Group AG Key News
7.7 Merck KGaA Inc.
7.7.1 Merck KGaA Inc. Corporate Summary
7.7.2 Merck KGaA Inc. Business Overview
7.7.3 Merck KGaA Inc. Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.7.4 Merck KGaA Inc. Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2017-2022)
7.7.5 Merck KGaA Inc. Key News
7.8 Oxford Biomedica Plc
7.8.1 Oxford Biomedica Plc Corporate Summary
7.8.2 Oxford Biomedica Plc Business Overview
7.8.3 Oxford Biomedica Plc Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.8.4 Oxford Biomedica Plc Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2017-2022)
7.8.5 Oxford Biomedica Plc Key News
7.9 Sartorius AG
7.9.1 Sartorius AG Corporate Summary
7.9.2 Sartorius AG Business Overview
7.9.3 Sartorius AG Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.9.4 Sartorius AG Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2017-2022)
7.9.5 Sartorius AG Key News
7.10 Takara Bio Inc.
7.10.1 Takara Bio Inc. Corporate Summary
7.10.2 Takara Bio Inc. Business Overview
7.10.3 Takara Bio Inc. Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.10.4 Takara Bio Inc. Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2017-2022)
7.10.5 Takara Bio Inc. Key News
7.11 Thermo Fisher Scientific Inc.
7.11.1 Thermo Fisher Scientific Inc. Corporate Summary
7.11.2 Thermo Fisher Scientific Inc. Business Overview
7.11.3 Thermo Fisher Scientific Inc. Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.11.4 Thermo Fisher Scientific Inc. Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2017-2022)
7.11.5 Thermo Fisher Scientific Inc. Key News
7.12 Wuxi AppTec
7.12.1 Wuxi AppTec Corporate Summary
7.12.2 Wuxi AppTec Business Overview
7.12.3 Wuxi AppTec Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.12.4 Wuxi AppTec Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2017-2022)
7.12.5 Wuxi AppTec Key News
7.13 Acuitas Therapeutics
7.13.1 Acuitas Therapeutics Corporate Summary
7.13.2 Acuitas Therapeutics Business Overview
7.13.3 Acuitas Therapeutics Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.13.4 Acuitas Therapeutics Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2017-2022)
7.13.5 Acuitas Therapeutics Key News
7.14 Evonik Industries AG
7.14.1 Evonik Industries AG Corporate Summary
7.14.2 Evonik Industries AG Business Overview
7.14.3 Evonik Industries AG Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.14.4 Evonik Industries AG Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2017-2022)
7.14.5 Evonik Industries AG Key News
7.15 Exelead, Inc.
7.15.1 Exelead, Inc. Corporate Summary
7.15.2 Exelead, Inc. Business Overview
7.15.3 Exelead, Inc. Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.15.4 Exelead, Inc. Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2017-2022)
7.15.5 Exelead, Inc. Key News
7.16 Entos Pharmaceuticals
7.16.1 Entos Pharmaceuticals Corporate Summary
7.16.2 Entos Pharmaceuticals Business Overview
7.16.3 Entos Pharmaceuticals Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.16.4 Entos Pharmaceuticals Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2017-2022)
7.16.5 Entos Pharmaceuticals Key News
7.17 Genevant Sciences GmbH
7.17.1 Genevant Sciences GmbH Corporate Summary
7.17.2 Genevant Sciences GmbH Business Overview
7.17.3 Genevant Sciences GmbH Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.17.4 Genevant Sciences GmbH Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2017-2022)
7.17.5 Genevant Sciences GmbH Key News
7.18 T&T Scientific Corporation
7.18.1 T&T Scientific Corporation Corporate Summary
7.18.2 T&T Scientific Corporation Business Overview
7.18.3 T&T Scientific Corporation Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.18.4 T&T Scientific Corporation Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2017-2022)
7.18.5 T&T Scientific Corporation Key News
7.19 Moderna, Inc.
7.19.1 Moderna, Inc. Corporate Summary
7.19.2 Moderna, Inc. Business Overview
7.19.3 Moderna, Inc. Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.19.4 Moderna, Inc. Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2017-2022)
7.19.5 Moderna, Inc. Key News
7.20 CureVac N.V.
7.20.1 CureVac N.V. Corporate Summary
7.20.2 CureVac N.V. Business Overview
7.20.3 CureVac N.V. Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.20.4 CureVac N.V. Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2017-2022)
7.20.5 CureVac N.V. Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 Viral and Non-Viral Vector Manufacturing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Viral and Non-Viral Vector Manufacturing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL VIRAL AND NON-VIRAL VECTOR MANUFACTURING OVERALL MARKET SIZE
2.1 Global Viral and Non-Viral Vector Manufacturing Market Size: 2021 VS 2028
2.2 Global Viral and Non-Viral Vector Manufacturing Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Viral and Non-Viral Vector Manufacturing Players in Global Market
3.2 Top Global Viral and Non-Viral Vector Manufacturing Companies Ranked by Revenue
3.3 Global Viral and Non-Viral Vector Manufacturing Revenue by Companies
3.4 Top 3 and Top 5 Viral and Non-Viral Vector Manufacturing Companies in Global Market, by Revenue in 2021
3.5 Global Companies Viral and Non-Viral Vector Manufacturing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Viral and Non-Viral Vector Manufacturing Players in Global Market
3.6.1 List of Global Tier 1 Viral and Non-Viral Vector Manufacturing Companies
3.6.2 List of Global Tier 2 and Tier 3 Viral and Non-Viral Vector Manufacturing Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Viral and Non-Viral Vector Manufacturing Market Size Markets, 2021 & 2028
4.1.2 Viral Vectors
4.1.3 Non-Viral Vectors
4.2 By Type - Global Viral and Non-Viral Vector Manufacturing Revenue & Forecasts
4.2.1 By Type - Global Viral and Non-Viral Vector Manufacturing Revenue, 2017-2022
4.2.2 By Type - Global Viral and Non-Viral Vector Manufacturing Revenue, 2023-2028
4.2.3 By Type - Global Viral and Non-Viral Vector Manufacturing Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Viral and Non-Viral Vector Manufacturing Market Size, 2021 & 2028
5.1.2 Gene Therapy
5.1.3 Vaccinology
5.1.4 Cell Therapy
5.1.5 Others
5.2 By Application - Global Viral and Non-Viral Vector Manufacturing Revenue & Forecasts
5.2.1 By Application - Global Viral and Non-Viral Vector Manufacturing Revenue, 2017-2022
5.2.2 By Application - Global Viral and Non-Viral Vector Manufacturing Revenue, 2023-2028
5.2.3 By Application - Global Viral and Non-Viral Vector Manufacturing Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Viral and Non-Viral Vector Manufacturing Market Size, 2021 & 2028
6.2 By Region - Global Viral and Non-Viral Vector Manufacturing Revenue & Forecasts
6.2.1 By Region - Global Viral and Non-Viral Vector Manufacturing Revenue, 2017-2022
6.2.2 By Region - Global Viral and Non-Viral Vector Manufacturing Revenue, 2023-2028
6.2.3 By Region - Global Viral and Non-Viral Vector Manufacturing Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Viral and Non-Viral Vector Manufacturing Revenue, 2017-2028
6.3.2 US Viral and Non-Viral Vector Manufacturing Market Size, 2017-2028
6.3.3 Canada Viral and Non-Viral Vector Manufacturing Market Size, 2017-2028
6.3.4 Mexico Viral and Non-Viral Vector Manufacturing Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Viral and Non-Viral Vector Manufacturing Revenue, 2017-2028
6.4.2 Germany Viral and Non-Viral Vector Manufacturing Market Size, 2017-2028
6.4.3 France Viral and Non-Viral Vector Manufacturing Market Size, 2017-2028
6.4.4 U.K. Viral and Non-Viral Vector Manufacturing Market Size, 2017-2028
6.4.5 Italy Viral and Non-Viral Vector Manufacturing Market Size, 2017-2028
6.4.6 Russia Viral and Non-Viral Vector Manufacturing Market Size, 2017-2028
6.4.7 Nordic Countries Viral and Non-Viral Vector Manufacturing Market Size, 2017-2028
6.4.8 Benelux Viral and Non-Viral Vector Manufacturing Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Viral and Non-Viral Vector Manufacturing Revenue, 2017-2028
6.5.2 China Viral and Non-Viral Vector Manufacturing Market Size, 2017-2028
6.5.3 Japan Viral and Non-Viral Vector Manufacturing Market Size, 2017-2028
6.5.4 South Korea Viral and Non-Viral Vector Manufacturing Market Size, 2017-2028
6.5.5 Southeast Asia Viral and Non-Viral Vector Manufacturing Market Size, 2017-2028
6.5.6 India Viral and Non-Viral Vector Manufacturing Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Viral and Non-Viral Vector Manufacturing Revenue, 2017-2028
6.6.2 Brazil Viral and Non-Viral Vector Manufacturing Market Size, 2017-2028
6.6.3 Argentina Viral and Non-Viral Vector Manufacturing Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Viral and Non-Viral Vector Manufacturing Revenue, 2017-2028
6.7.2 Turkey Viral and Non-Viral Vector Manufacturing Market Size, 2017-2028
6.7.3 Israel Viral and Non-Viral Vector Manufacturing Market Size, 2017-2028
6.7.4 Saudi Arabia Viral and Non-Viral Vector Manufacturing Market Size, 2017-2028
6.7.5 UAE Viral and Non-Viral Vector Manufacturing Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Boehringer Ingelheim
7.1.1 Boehringer Ingelheim Corporate Summary
7.1.2 Boehringer Ingelheim Business Overview
7.1.3 Boehringer Ingelheim Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.1.4 Boehringer Ingelheim Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2017-2022)
7.1.5 Boehringer Ingelheim Key News
7.2 Catalent, Inc.
7.2.1 Catalent, Inc. Corporate Summary
7.2.2 Catalent, Inc. Business Overview
7.2.3 Catalent, Inc. Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.2.4 Catalent, Inc. Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2017-2022)
7.2.5 Catalent, Inc. Key News
7.3 FUJIFILM Holdings Corporation
7.3.1 FUJIFILM Holdings Corporation Corporate Summary
7.3.2 FUJIFILM Holdings Corporation Business Overview
7.3.3 FUJIFILM Holdings Corporation Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.3.4 FUJIFILM Holdings Corporation Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2017-2022)
7.3.5 FUJIFILM Holdings Corporation Key News
7.4 Danaher Corporation
7.4.1 Danaher Corporation Corporate Summary
7.4.2 Danaher Corporation Business Overview
7.4.3 Danaher Corporation Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.4.4 Danaher Corporation Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2017-2022)
7.4.5 Danaher Corporation Key News
7.5 Genscript Biotech Corporation
7.5.1 Genscript Biotech Corporation Corporate Summary
7.5.2 Genscript Biotech Corporation Business Overview
7.5.3 Genscript Biotech Corporation Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.5.4 Genscript Biotech Corporation Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2017-2022)
7.5.5 Genscript Biotech Corporation Key News
7.6 Lonza Group AG
7.6.1 Lonza Group AG Corporate Summary
7.6.2 Lonza Group AG Business Overview
7.6.3 Lonza Group AG Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.6.4 Lonza Group AG Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2017-2022)
7.6.5 Lonza Group AG Key News
7.7 Merck KGaA Inc.
7.7.1 Merck KGaA Inc. Corporate Summary
7.7.2 Merck KGaA Inc. Business Overview
7.7.3 Merck KGaA Inc. Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.7.4 Merck KGaA Inc. Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2017-2022)
7.7.5 Merck KGaA Inc. Key News
7.8 Oxford Biomedica Plc
7.8.1 Oxford Biomedica Plc Corporate Summary
7.8.2 Oxford Biomedica Plc Business Overview
7.8.3 Oxford Biomedica Plc Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.8.4 Oxford Biomedica Plc Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2017-2022)
7.8.5 Oxford Biomedica Plc Key News
7.9 Sartorius AG
7.9.1 Sartorius AG Corporate Summary
7.9.2 Sartorius AG Business Overview
7.9.3 Sartorius AG Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.9.4 Sartorius AG Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2017-2022)
7.9.5 Sartorius AG Key News
7.10 Takara Bio Inc.
7.10.1 Takara Bio Inc. Corporate Summary
7.10.2 Takara Bio Inc. Business Overview
7.10.3 Takara Bio Inc. Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.10.4 Takara Bio Inc. Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2017-2022)
7.10.5 Takara Bio Inc. Key News
7.11 Thermo Fisher Scientific Inc.
7.11.1 Thermo Fisher Scientific Inc. Corporate Summary
7.11.2 Thermo Fisher Scientific Inc. Business Overview
7.11.3 Thermo Fisher Scientific Inc. Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.11.4 Thermo Fisher Scientific Inc. Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2017-2022)
7.11.5 Thermo Fisher Scientific Inc. Key News
7.12 Wuxi AppTec
7.12.1 Wuxi AppTec Corporate Summary
7.12.2 Wuxi AppTec Business Overview
7.12.3 Wuxi AppTec Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.12.4 Wuxi AppTec Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2017-2022)
7.12.5 Wuxi AppTec Key News
7.13 Acuitas Therapeutics
7.13.1 Acuitas Therapeutics Corporate Summary
7.13.2 Acuitas Therapeutics Business Overview
7.13.3 Acuitas Therapeutics Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.13.4 Acuitas Therapeutics Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2017-2022)
7.13.5 Acuitas Therapeutics Key News
7.14 Evonik Industries AG
7.14.1 Evonik Industries AG Corporate Summary
7.14.2 Evonik Industries AG Business Overview
7.14.3 Evonik Industries AG Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.14.4 Evonik Industries AG Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2017-2022)
7.14.5 Evonik Industries AG Key News
7.15 Exelead, Inc.
7.15.1 Exelead, Inc. Corporate Summary
7.15.2 Exelead, Inc. Business Overview
7.15.3 Exelead, Inc. Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.15.4 Exelead, Inc. Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2017-2022)
7.15.5 Exelead, Inc. Key News
7.16 Entos Pharmaceuticals
7.16.1 Entos Pharmaceuticals Corporate Summary
7.16.2 Entos Pharmaceuticals Business Overview
7.16.3 Entos Pharmaceuticals Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.16.4 Entos Pharmaceuticals Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2017-2022)
7.16.5 Entos Pharmaceuticals Key News
7.17 Genevant Sciences GmbH
7.17.1 Genevant Sciences GmbH Corporate Summary
7.17.2 Genevant Sciences GmbH Business Overview
7.17.3 Genevant Sciences GmbH Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.17.4 Genevant Sciences GmbH Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2017-2022)
7.17.5 Genevant Sciences GmbH Key News
7.18 T&T Scientific Corporation
7.18.1 T&T Scientific Corporation Corporate Summary
7.18.2 T&T Scientific Corporation Business Overview
7.18.3 T&T Scientific Corporation Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.18.4 T&T Scientific Corporation Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2017-2022)
7.18.5 T&T Scientific Corporation Key News
7.19 Moderna, Inc.
7.19.1 Moderna, Inc. Corporate Summary
7.19.2 Moderna, Inc. Business Overview
7.19.3 Moderna, Inc. Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.19.4 Moderna, Inc. Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2017-2022)
7.19.5 Moderna, Inc. Key News
7.20 CureVac N.V.
7.20.1 CureVac N.V. Corporate Summary
7.20.2 CureVac N.V. Business Overview
7.20.3 CureVac N.V. Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.20.4 CureVac N.V. Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2017-2022)
7.20.5 CureVac N.V. Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. Viral and Non-Viral Vector Manufacturing Market Opportunities & Trends in Global Market
Table 2. Viral and Non-Viral Vector Manufacturing Market Drivers in Global Market
Table 3. Viral and Non-Viral Vector Manufacturing Market Restraints in Global Market
Table 4. Key Players of Viral and Non-Viral Vector Manufacturing in Global Market
Table 5. Top Viral and Non-Viral Vector Manufacturing Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Viral and Non-Viral Vector Manufacturing Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Viral and Non-Viral Vector Manufacturing Revenue Share by Companies, 2017-2022
Table 8. Global Companies Viral and Non-Viral Vector Manufacturing Product Type
Table 9. List of Global Tier 1 Viral and Non-Viral Vector Manufacturing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Viral and Non-Viral Vector Manufacturing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Viral and Non-Viral Vector Manufacturing Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Viral and Non-Viral Vector Manufacturing Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Viral and Non-Viral Vector Manufacturing Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Viral and Non-Viral Vector Manufacturing Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2023-2028
Table 30. Boehringer Ingelheim Corporate Summary
Table 31. Boehringer Ingelheim Viral and Non-Viral Vector Manufacturing Product Offerings
Table 32. Boehringer Ingelheim Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), (2017-2022)
Table 33. Catalent, Inc. Corporate Summary
Table 34. Catalent, Inc. Viral and Non-Viral Vector Manufacturing Product Offerings
Table 35. Catalent, Inc. Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), (2017-2022)
Table 36. FUJIFILM Holdings Corporation Corporate Summary
Table 37. FUJIFILM Holdings Corporation Viral and Non-Viral Vector Manufacturing Product Offerings
Table 38. FUJIFILM Holdings Corporation Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), (2017-2022)
Table 39. Danaher Corporation Corporate Summary
Table 40. Danaher Corporation Viral and Non-Viral Vector Manufacturing Product Offerings
Table 41. Danaher Corporation Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), (2017-2022)
Table 42. Genscript Biotech Corporation Corporate Summary
Table 43. Genscript Biotech Corporation Viral and Non-Viral Vector Manufacturing Product Offerings
Table 44. Genscript Biotech Corporation Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), (2017-2022)
Table 45. Lonza Group AG Corporate Summary
Table 46. Lonza Group AG Viral and Non-Viral Vector Manufacturing Product Offerings
Table 47. Lonza Group AG Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), (2017-2022)
Table 48. Merck KGaA Inc. Corporate Summary
Table 49. Merck KGaA Inc. Viral and Non-Viral Vector Manufacturing Product Offerings
Table 50. Merck KGaA Inc. Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), (2017-2022)
Table 51. Oxford Biomedica Plc Corporate Summary
Table 52. Oxford Biomedica Plc Viral and Non-Viral Vector Manufacturing Product Offerings
Table 53. Oxford Biomedica Plc Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), (2017-2022)
Table 54. Sartorius AG Corporate Summary
Table 55. Sartorius AG Viral and Non-Viral Vector Manufacturing Product Offerings
Table 56. Sartorius AG Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), (2017-2022)
Table 57. Takara Bio Inc. Corporate Summary
Table 58. Takara Bio Inc. Viral and Non-Viral Vector Manufacturing Product Offerings
Table 59. Takara Bio Inc. Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), (2017-2022)
Table 60. Thermo Fisher Scientific Inc. Corporate Summary
Table 61. Thermo Fisher Scientific Inc. Viral and Non-Viral Vector Manufacturing Product Offerings
Table 62. Thermo Fisher Scientific Inc. Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), (2017-2022)
Table 63. Wuxi AppTec Corporate Summary
Table 64. Wuxi AppTec Viral and Non-Viral Vector Manufacturing Product Offerings
Table 65. Wuxi AppTec Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), (2017-2022)
Table 66. Acuitas Therapeutics Corporate Summary
Table 67. Acuitas Therapeutics Viral and Non-Viral Vector Manufacturing Product Offerings
Table 68. Acuitas Therapeutics Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), (2017-2022)
Table 69. Evonik Industries AG Corporate Summary
Table 70. Evonik Industries AG Viral and Non-Viral Vector Manufacturing Product Offerings
Table 71. Evonik Industries AG Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), (2017-2022)
Table 72. Exelead, Inc. Corporate Summary
Table 73. Exelead, Inc. Viral and Non-Viral Vector Manufacturing Product Offerings
Table 74. Exelead, Inc. Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), (2017-2022)
Table 75. Entos Pharmaceuticals Corporate Summary
Table 76. Entos Pharmaceuticals Viral and Non-Viral Vector Manufacturing Product Offerings
Table 77. Entos Pharmaceuticals Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), (2017-2022)
Table 78. Genevant Sciences GmbH Corporate Summary
Table 79. Genevant Sciences GmbH Viral and Non-Viral Vector Manufacturing Product Offerings
Table 80. Genevant Sciences GmbH Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), (2017-2022)
Table 81. T&T Scientific Corporation Corporate Summary
Table 82. T&T Scientific Corporation Viral and Non-Viral Vector Manufacturing Product Offerings
Table 83. T&T Scientific Corporation Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), (2017-2022)
Table 84. Moderna, Inc. Corporate Summary
Table 85. Moderna, Inc. Viral and Non-Viral Vector Manufacturing Product Offerings
Table 86. Moderna, Inc. Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), (2017-2022)
Table 87. CureVac N.V. Corporate Summary
Table 88. CureVac N.V. Viral and Non-Viral Vector Manufacturing Product Offerings
Table 89. CureVac N.V. Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), (2017-2022)
Table 1. Viral and Non-Viral Vector Manufacturing Market Opportunities & Trends in Global Market
Table 2. Viral and Non-Viral Vector Manufacturing Market Drivers in Global Market
Table 3. Viral and Non-Viral Vector Manufacturing Market Restraints in Global Market
Table 4. Key Players of Viral and Non-Viral Vector Manufacturing in Global Market
Table 5. Top Viral and Non-Viral Vector Manufacturing Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Viral and Non-Viral Vector Manufacturing Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Viral and Non-Viral Vector Manufacturing Revenue Share by Companies, 2017-2022
Table 8. Global Companies Viral and Non-Viral Vector Manufacturing Product Type
Table 9. List of Global Tier 1 Viral and Non-Viral Vector Manufacturing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Viral and Non-Viral Vector Manufacturing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Viral and Non-Viral Vector Manufacturing Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Viral and Non-Viral Vector Manufacturing Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Viral and Non-Viral Vector Manufacturing Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Viral and Non-Viral Vector Manufacturing Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2023-2028
Table 30. Boehringer Ingelheim Corporate Summary
Table 31. Boehringer Ingelheim Viral and Non-Viral Vector Manufacturing Product Offerings
Table 32. Boehringer Ingelheim Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), (2017-2022)
Table 33. Catalent, Inc. Corporate Summary
Table 34. Catalent, Inc. Viral and Non-Viral Vector Manufacturing Product Offerings
Table 35. Catalent, Inc. Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), (2017-2022)
Table 36. FUJIFILM Holdings Corporation Corporate Summary
Table 37. FUJIFILM Holdings Corporation Viral and Non-Viral Vector Manufacturing Product Offerings
Table 38. FUJIFILM Holdings Corporation Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), (2017-2022)
Table 39. Danaher Corporation Corporate Summary
Table 40. Danaher Corporation Viral and Non-Viral Vector Manufacturing Product Offerings
Table 41. Danaher Corporation Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), (2017-2022)
Table 42. Genscript Biotech Corporation Corporate Summary
Table 43. Genscript Biotech Corporation Viral and Non-Viral Vector Manufacturing Product Offerings
Table 44. Genscript Biotech Corporation Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), (2017-2022)
Table 45. Lonza Group AG Corporate Summary
Table 46. Lonza Group AG Viral and Non-Viral Vector Manufacturing Product Offerings
Table 47. Lonza Group AG Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), (2017-2022)
Table 48. Merck KGaA Inc. Corporate Summary
Table 49. Merck KGaA Inc. Viral and Non-Viral Vector Manufacturing Product Offerings
Table 50. Merck KGaA Inc. Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), (2017-2022)
Table 51. Oxford Biomedica Plc Corporate Summary
Table 52. Oxford Biomedica Plc Viral and Non-Viral Vector Manufacturing Product Offerings
Table 53. Oxford Biomedica Plc Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), (2017-2022)
Table 54. Sartorius AG Corporate Summary
Table 55. Sartorius AG Viral and Non-Viral Vector Manufacturing Product Offerings
Table 56. Sartorius AG Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), (2017-2022)
Table 57. Takara Bio Inc. Corporate Summary
Table 58. Takara Bio Inc. Viral and Non-Viral Vector Manufacturing Product Offerings
Table 59. Takara Bio Inc. Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), (2017-2022)
Table 60. Thermo Fisher Scientific Inc. Corporate Summary
Table 61. Thermo Fisher Scientific Inc. Viral and Non-Viral Vector Manufacturing Product Offerings
Table 62. Thermo Fisher Scientific Inc. Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), (2017-2022)
Table 63. Wuxi AppTec Corporate Summary
Table 64. Wuxi AppTec Viral and Non-Viral Vector Manufacturing Product Offerings
Table 65. Wuxi AppTec Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), (2017-2022)
Table 66. Acuitas Therapeutics Corporate Summary
Table 67. Acuitas Therapeutics Viral and Non-Viral Vector Manufacturing Product Offerings
Table 68. Acuitas Therapeutics Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), (2017-2022)
Table 69. Evonik Industries AG Corporate Summary
Table 70. Evonik Industries AG Viral and Non-Viral Vector Manufacturing Product Offerings
Table 71. Evonik Industries AG Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), (2017-2022)
Table 72. Exelead, Inc. Corporate Summary
Table 73. Exelead, Inc. Viral and Non-Viral Vector Manufacturing Product Offerings
Table 74. Exelead, Inc. Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), (2017-2022)
Table 75. Entos Pharmaceuticals Corporate Summary
Table 76. Entos Pharmaceuticals Viral and Non-Viral Vector Manufacturing Product Offerings
Table 77. Entos Pharmaceuticals Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), (2017-2022)
Table 78. Genevant Sciences GmbH Corporate Summary
Table 79. Genevant Sciences GmbH Viral and Non-Viral Vector Manufacturing Product Offerings
Table 80. Genevant Sciences GmbH Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), (2017-2022)
Table 81. T&T Scientific Corporation Corporate Summary
Table 82. T&T Scientific Corporation Viral and Non-Viral Vector Manufacturing Product Offerings
Table 83. T&T Scientific Corporation Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), (2017-2022)
Table 84. Moderna, Inc. Corporate Summary
Table 85. Moderna, Inc. Viral and Non-Viral Vector Manufacturing Product Offerings
Table 86. Moderna, Inc. Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), (2017-2022)
Table 87. CureVac N.V. Corporate Summary
Table 88. CureVac N.V. Viral and Non-Viral Vector Manufacturing Product Offerings
Table 89. CureVac N.V. Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), (2017-2022)
LIST OF FIGURES
Figure 1. Viral and Non-Viral Vector Manufacturing Segment by Type in 2021
Figure 2. Viral and Non-Viral Vector Manufacturing Segment by Application in 2021
Figure 3. Global Viral and Non-Viral Vector Manufacturing Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Viral and Non-Viral Vector Manufacturing Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Viral and Non-Viral Vector Manufacturing Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Viral and Non-Viral Vector Manufacturing Revenue in 2021
Figure 8. By Type - Global Viral and Non-Viral Vector Manufacturing Revenue Market Share, 2017-2028
Figure 9. By Application - Global Viral and Non-Viral Vector Manufacturing Revenue Market Share, 2017-2028
Figure 10. By Region - Global Viral and Non-Viral Vector Manufacturing Revenue Market Share, 2017-2028
Figure 11. By Country - North America Viral and Non-Viral Vector Manufacturing Revenue Market Share, 2017-2028
Figure 12. US Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Viral and Non-Viral Vector Manufacturing Revenue Market Share, 2017-2028
Figure 16. Germany Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 17. France Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Viral and Non-Viral Vector Manufacturing Revenue Market Share, 2017-2028
Figure 24. China Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 28. India Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Viral and Non-Viral Vector Manufacturing Revenue Market Share, 2017-2028
Figure 30. Brazil Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Viral and Non-Viral Vector Manufacturing Revenue Market Share, 2017-2028
Figure 33. Turkey Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 37. Boehringer Ingelheim Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Catalent, Inc. Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. FUJIFILM Holdings Corporation Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Danaher Corporation Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Genscript Biotech Corporation Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Lonza Group AG Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Merck KGaA Inc. Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Oxford Biomedica Plc Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Sartorius AG Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Takara Bio Inc. Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Thermo Fisher Scientific Inc. Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Wuxi AppTec Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Acuitas Therapeutics Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Evonik Industries AG Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Exelead, Inc. Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Entos Pharmaceuticals Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Genevant Sciences GmbH Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. T&T Scientific Corporation Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Moderna, Inc. Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. CureVac N.V. Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 1. Viral and Non-Viral Vector Manufacturing Segment by Type in 2021
Figure 2. Viral and Non-Viral Vector Manufacturing Segment by Application in 2021
Figure 3. Global Viral and Non-Viral Vector Manufacturing Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Viral and Non-Viral Vector Manufacturing Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Viral and Non-Viral Vector Manufacturing Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Viral and Non-Viral Vector Manufacturing Revenue in 2021
Figure 8. By Type - Global Viral and Non-Viral Vector Manufacturing Revenue Market Share, 2017-2028
Figure 9. By Application - Global Viral and Non-Viral Vector Manufacturing Revenue Market Share, 2017-2028
Figure 10. By Region - Global Viral and Non-Viral Vector Manufacturing Revenue Market Share, 2017-2028
Figure 11. By Country - North America Viral and Non-Viral Vector Manufacturing Revenue Market Share, 2017-2028
Figure 12. US Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Viral and Non-Viral Vector Manufacturing Revenue Market Share, 2017-2028
Figure 16. Germany Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 17. France Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Viral and Non-Viral Vector Manufacturing Revenue Market Share, 2017-2028
Figure 24. China Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 28. India Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Viral and Non-Viral Vector Manufacturing Revenue Market Share, 2017-2028
Figure 30. Brazil Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Viral and Non-Viral Vector Manufacturing Revenue Market Share, 2017-2028
Figure 33. Turkey Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 37. Boehringer Ingelheim Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Catalent, Inc. Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. FUJIFILM Holdings Corporation Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Danaher Corporation Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Genscript Biotech Corporation Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Lonza Group AG Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Merck KGaA Inc. Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Oxford Biomedica Plc Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Sartorius AG Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Takara Bio Inc. Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Thermo Fisher Scientific Inc. Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Wuxi AppTec Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Acuitas Therapeutics Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Evonik Industries AG Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Exelead, Inc. Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Entos Pharmaceuticals Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Genevant Sciences GmbH Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. T&T Scientific Corporation Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Moderna, Inc. Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. CureVac N.V. Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
